We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 8th:
Louisiana-Pacific Corporation (LPX - Free Report) : This building products manufacturer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days.
Xcerra Corporation : This test and handling capital equipment provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 38.6% over the last 60 days.
NCI Building Systems, Inc. : This metal products manufacturer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.
Leucadia National Corporation : This diversified holding company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 14.4% over the last 60 days.
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Top Ranked Value Stocks to Buy for January 8th
Here are four stocks with buy rank and strong value characteristics for investors to consider today, January 8th:
Louisiana-Pacific Corporation (LPX - Free Report) : This building products manufacturer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days.
Louisiana-Pacific Corporation Price and Consensus
Louisiana-Pacific Corporation Price and Consensus | Louisiana-Pacific Corporation Quote
Louisiana-Pacific has a price-to-earnings ratio (P/E) of 15.00, compared with 42.30 for the industry. The company possesses a Value Score of A.
Louisiana-Pacific Corporation PE Ratio (TTM)
Louisiana-Pacific Corporation PE Ratio (TTM) | Louisiana-Pacific Corporation Quote
Xcerra Corporation : This test and handling capital equipment provider has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 38.6% over the last 60 days.
Xcerra Corporation Price and Consensus
Xcerra Corporation Price and Consensus | Xcerra Corporation Quote
Xcerra has a price-to-earnings ratio (P/E) of 10.31, compared with 24.30 for the industry. The company possesses a Value Score of A.
Xcerra Corporation PE Ratio (TTM)
Xcerra Corporation PE Ratio (TTM) | Xcerra Corporation Quote
NCI Building Systems, Inc. : This metal products manufacturer has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.
NCI Building Systems, Inc. Price and Consensus
NCI Building Systems, Inc. Price and Consensus | NCI Building Systems, Inc. Quote
NCI Building Systems has a price-to-earnings ratio (P/E) of 18.18, compared with 26.40 for the industry. The company possesses a Value Score of A.
NCI Building Systems, Inc. PE Ratio (TTM)
NCI Building Systems, Inc. PE Ratio (TTM) | NCI Building Systems, Inc. Quote
Leucadia National Corporation : This diversified holding company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 14.4% over the last 60 days.
Leucadia National Corporation Price and Consensus
Leucadia National Corporation Price and Consensus | Leucadia National Corporation Quote
Leucadia National has a price-to-earnings ratio (P/E) of 16.59, compared with 28.10 for the industry. The company possesses a Value Score of A.
Leucadia National Corporation PE Ratio (TTM)
Leucadia National Corporation PE Ratio (TTM) | Leucadia National Corporation Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>